Guardant Health Inc. | Mid-cap | Healthcare
$50.50
0.64%
| Guardant Health Stock Comparison:
Guardant Health vs Thermo FisherGuardant Health vs DanaherGuardant Health vs Qiagen N.VGuardant Health vs Medpace HoldingsGuardant Health vs Charles RiverGuardant Health vs S&P 500 | Market
Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 739.0M
Gross Profit 449.2M 60.79%
Operating Income -443.6M -60.02%
Net Income -436.4M -59.05%
EPS (Diluted) -$3.56

Balance Sheet Metrics

Total Assets 1.5B
Total Liabilities 1.6B
Shareholders Equity -139.6M

Cash Flow Metrics

Operating Cash Flow -267.0M
Free Cash Flow -274.9M

Revenue & Profitability Trend

Guardant Health Income Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Revenue 739.0M 563.9M 449.5M 373.7M 286.7M
Cost of Goods Sold 289.8M 227.1M 156.3M 122.9M 92.5M
Gross Profit 449.2M 336.9M 293.2M 250.7M 194.2M
Operating Expenses 892.8M 901.6M 837.6M 661.7M 449.1M
Operating Income -443.6M -564.7M -544.4M -411.0M -255.0M
Pre-tax Income -435.1M -478.8M -653.4M -384.5M -245.9M
Income Tax 1.3M 685.0K 1.1M 300.0K 379.0K
Net Income -436.4M -479.4M -654.6M -384.8M -246.3M
EPS (Diluted) -$3.56 -$4.28 -$6.41 -$4.00 -$2.60

Income Statement Trend

Guardant Health Balance Sheet From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Assets
Current Assets 1.1B 1.3B 1.2B 1.1B 1.9B
Non-Current Assets 430.5M 439.3M 418.4M 1.1B 383.4M
Total Assets 1.5B 1.8B 1.6B 2.2B 2.3B
Liabilities
Current Liabilities 225.6M 205.9M 193.2M 194.7M 66.8M
Non-Current Liabilities 1.4B 1.4B 1.4B 1.4B 849.4M
Total Liabilities 1.6B 1.6B 1.5B 1.6B 916.2M
Equity
Total Shareholders Equity -139.6M 158.7M 60.2M 645.0M 1.4B

Balance Sheet Composition

Guardant Health Cash Flow Statement From 2020 to 2024

Metric 2024 2023 2022 2021 2020
Operating Activities
Net Income -436.4M -479.4M -654.6M -384.8M -246.3M
Operating Cash Flow -267.0M -345.0M -347.6M -212.3M -107.7M
Investing Activities
Capital Expenditures -35.1M -20.5M -77.5M -75.0M -36.2M
Investing Cash Flow -261.3M 840.2M 149.8M -63.2M -599.2M
Financing Activities
Dividends Paid - - - - -
Financing Cash Flow -15.8M 466.8M -201.1M -84.8M 1.4B
Free Cash Flow -274.9M -345.5M -386.9M -284.1M -158.0M

Cash Flow Trend

Guardant Health Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) -14.19
Forward P/E -17.92
Price to Book -24.95
Price to Sales 7.77
PEG Ratio -17.92

Profitability Ratios

Profit Margin -53.82%
Operating Margin -54.33%
Return on Equity 312.48%
Return on Assets -18.64%

Financial Health

Current Ratio 4.11
Debt to Equity -5.21
Beta 1.38

Per Share Data

EPS (TTM) -$3.39
Book Value per Share -$2.03
Revenue per Share $6.28

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
gh 6.0B -14.19 -24.95 312.48% -53.82% -5.21
Thermo Fisher 152.5B 23.69 3.09 13.70% 15.19% 69.23
Danaher 140.5B 37.98 2.76 7.22% 15.81% 34.56
Qiagen N.V 10.1B 108.63 2.97 2.67% 4.68% 41.36
Medpace Holdings 8.9B 23.58 15.48 65.83% 19.31% 25.33
Charles River 7.2B 681.33 2.27 -0.67% -0.49% 92.21

Financial data is updated regularly. All figures are in the company's reporting currency.